rAAV-delivered PTEN therapeutics for prostate cancer

• Päätekijät: Jianzhong Ai (Tekijä), Jia Li (Tekijä), Qin Su (Tekijä), Hong Ma (Tekijä), Qiang Wei (Tekijä), Hong Li (Tekijä), Guangping Gao (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2022-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Effective treatments for prostate cancer (PCa) require further development, and previous studies have reported that PTEN and its downstream target CDKN1B are significantly downregulated in PCa cells compared with normal cells. Therefore, modulation of PTEN and CDKN1B expression might be a promising...